IPCI - Intellipharmaceutics International Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue11/30/201811/30/201711/30/201611/30/2015
Total Revenue-5,504.4522,247.0024,093.781
Cost of Revenue-704.006--
Gross Profit-4,800.4462,247.0024,093.781
Operating Expenses
Research Development-9,271.3538,166.7367,247.473
Selling General and Administrative-3,287.9143,546.1323,581.913
Non Recurring----
Others----
Total Operating Expenses-13,770.23412,098.07811,207.235
Operating Income or Loss--8,265.782-9,851.076-7,113.454
Income from Continuing Operations
Total Other Income/Expenses Net--591.658-292.501-322.934
Earnings Before Interest and Taxes--8,265.782-9,851.076-7,113.454
Interest Expense--389.239-270.238-256.629
Income Before Tax--8,857.44-10,143.577-7,436.388
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops--8,857.44-10,143.577-7,436.388
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--8,857.44-10,143.577-7,436.388
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--8,857.44-10,143.577-7,436.388